“Steroid-Refractory Chronic Graft-Versus-Host Disease Treated With Ruxolitinib: A Narrative Review of Symptom Burden and Return to Daily Life”. 2023. Journal of Clinical Case Studies and Reviews 4 (1): 31-36. https://doi.org/10.5281/zenodo.22227762.